GO:0010467 | gene expression | 1.99e-04 | 1.00e+00 | 3.052 | 5 | 45 | 669 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0035964 | COPI-coated vesicle budding | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:1902003 | regulation of beta-amyloid formation | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0044822 | poly(A) RNA binding | 1.63e-03 | 1.00e+00 | 2.393 | 5 | 50 | 1056 |
GO:0070765 | gamma-secretase complex | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0006429 | leucyl-tRNA aminoacylation | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0004823 | leucine-tRNA ligase activity | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0016149 | translation release factor activity, codon specific | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0004768 | stearoyl-CoA 9-desaturase activity | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0055100 | adiponectin binding | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0003723 | RNA binding | 3.17e-03 | 1.00e+00 | 3.283 | 3 | 18 | 342 |
GO:0035459 | cargo loading into vesicle | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0030137 | COPI-coated vesicle | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0003747 | translation release factor activity | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 2 | 4 |
GO:0030308 | negative regulation of cell growth | 4.26e-03 | 1.00e+00 | 4.334 | 2 | 6 | 110 |
GO:0001714 | endodermal cell fate specification | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0043279 | response to alkaloid | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 2 | 5 |
GO:0006449 | regulation of translational termination | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 2 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0033211 | adiponectin-activated signaling pathway | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0006366 | transcription from RNA polymerase II promoter | 5.60e-03 | 1.00e+00 | 2.990 | 3 | 30 | 419 |
GO:0071354 | cellular response to interleukin-6 | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 7 |
GO:0002161 | aminoacyl-tRNA editing activity | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 7 |
GO:0042981 | regulation of apoptotic process | 7.77e-03 | 1.00e+00 | 3.887 | 2 | 4 | 150 |
GO:0006450 | regulation of translational fidelity | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 9 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 2 | 10 |
GO:0045055 | regulated secretory pathway | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 10 |
GO:0042589 | zymogen granule membrane | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 10 |
GO:0044212 | transcription regulatory region DNA binding | 9.67e-03 | 1.00e+00 | 3.723 | 2 | 17 | 168 |
GO:0019395 | fatty acid oxidation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 4 | 11 |
GO:0006886 | intracellular protein transport | 1.00e-02 | 1.00e+00 | 3.698 | 2 | 4 | 171 |
GO:0016607 | nuclear speck | 1.01e-02 | 1.00e+00 | 3.689 | 2 | 12 | 172 |
GO:0030667 | secretory granule membrane | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 2 | 12 |
GO:0030140 | trans-Golgi network transport vesicle | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 12 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 3 | 13 |
GO:0048205 | COPI coating of Golgi vesicle | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 2 | 13 |
GO:0030234 | enzyme regulator activity | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 2 | 13 |
GO:0006479 | protein methylation | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 14 |
GO:0005685 | U1 snRNP | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 14 |
GO:0005654 | nucleoplasm | 1.30e-02 | 1.00e+00 | 2.036 | 4 | 64 | 1082 |
GO:0048208 | COPII vesicle coating | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 15 |
GO:0006376 | mRNA splice site selection | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 15 |
GO:0042562 | hormone binding | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 16 |
GO:0043274 | phospholipase binding | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 16 |
GO:0006336 | DNA replication-independent nucleosome assembly | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 16 |
GO:0022624 | proteasome accessory complex | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 17 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 2 | 17 |
GO:0009755 | hormone-mediated signaling pathway | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 18 |
GO:0016071 | mRNA metabolic process | 1.66e-02 | 1.00e+00 | 3.315 | 2 | 8 | 223 |
GO:0008380 | RNA splicing | 1.73e-02 | 1.00e+00 | 3.283 | 2 | 22 | 228 |
GO:0006412 | translation | 1.76e-02 | 1.00e+00 | 3.270 | 2 | 8 | 230 |
GO:0016575 | histone deacetylation | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 3 | 21 |
GO:0016070 | RNA metabolic process | 2.01e-02 | 1.00e+00 | 3.167 | 2 | 8 | 247 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 3 | 24 |
GO:0046326 | positive regulation of glucose import | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 1 | 24 |
GO:0008536 | Ran GTPase binding | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 25 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 25 |
GO:0043022 | ribosome binding | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 1 | 27 |
GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 1 | 27 |
GO:0071897 | DNA biosynthetic process | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 1 | 28 |
GO:0030658 | transport vesicle membrane | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 1 | 32 |
GO:0006633 | fatty acid biosynthetic process | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 1 | 32 |
GO:0019905 | syntaxin binding | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 2 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 8 | 33 |
GO:0005801 | cis-Golgi network | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 1 | 33 |
GO:0016592 | mediator complex | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 10 | 35 |
GO:0051259 | protein oligomerization | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 2 | 39 |
GO:0035019 | somatic stem cell maintenance | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 6 | 40 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.72e-02 | 1.00e+00 | 4.723 | 1 | 3 | 42 |
GO:0031124 | mRNA 3'-end processing | 3.72e-02 | 1.00e+00 | 4.723 | 1 | 2 | 42 |
GO:0006369 | termination of RNA polymerase II transcription | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 2 | 45 |
GO:0005515 | protein binding | 4.29e-02 | 1.00e+00 | 0.729 | 9 | 198 | 6024 |
GO:0007030 | Golgi organization | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 3 | 49 |
GO:0003743 | translation initiation factor activity | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 7 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 1 | 50 |
GO:0009611 | response to wounding | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 5 | 52 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 4.68e-02 | 1.00e+00 | 4.388 | 1 | 1 | 53 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 2 | 56 |
GO:0005643 | nuclear pore | 5.02e-02 | 1.00e+00 | 4.283 | 1 | 11 | 57 |
GO:0000502 | proteasome complex | 5.11e-02 | 1.00e+00 | 4.258 | 1 | 3 | 58 |
GO:0006406 | mRNA export from nucleus | 5.36e-02 | 1.00e+00 | 4.185 | 1 | 4 | 61 |
GO:0016020 | membrane | 5.55e-02 | 1.00e+00 | 1.401 | 4 | 46 | 1681 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 5.62e-02 | 1.00e+00 | 4.116 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.71e-02 | 1.00e+00 | 4.093 | 1 | 2 | 65 |
GO:0005829 | cytosol | 5.88e-02 | 1.00e+00 | 1.152 | 5 | 86 | 2496 |
GO:0010468 | regulation of gene expression | 5.96e-02 | 1.00e+00 | 4.028 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 2 | 70 |
GO:0007584 | response to nutrient | 6.22e-02 | 1.00e+00 | 3.966 | 1 | 3 | 71 |
GO:0042826 | histone deacetylase binding | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 4 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 1 | 72 |
GO:0003729 | mRNA binding | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 4 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 2 | 74 |
GO:0008584 | male gonad development | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 3 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 1 | 75 |
GO:0044267 | cellular protein metabolic process | 6.62e-02 | 1.00e+00 | 2.227 | 2 | 20 | 474 |
GO:0007565 | female pregnancy | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 2 | 78 |
GO:0001822 | kidney development | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 3 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.89e-02 | 1.00e+00 | 3.812 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 7.23e-02 | 1.00e+00 | 3.741 | 1 | 2 | 83 |
GO:0006415 | translational termination | 7.57e-02 | 1.00e+00 | 3.673 | 1 | 2 | 87 |
GO:0042470 | melanosome | 7.90e-02 | 1.00e+00 | 3.608 | 1 | 2 | 91 |
GO:0001649 | osteoblast differentiation | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 5 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 1 | 92 |
GO:0005783 | endoplasmic reticulum | 8.74e-02 | 1.00e+00 | 1.997 | 2 | 13 | 556 |
GO:0005506 | iron ion binding | 9.07e-02 | 1.00e+00 | 3.401 | 1 | 3 | 105 |
GO:0005789 | endoplasmic reticulum membrane | 9.12e-02 | 1.00e+00 | 1.961 | 2 | 9 | 570 |
GO:0005737 | cytoplasm | 9.60e-02 | 1.00e+00 | 0.821 | 6 | 124 | 3767 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 9.81e-02 | 1.00e+00 | 3.283 | 1 | 4 | 114 |
GO:0000209 | protein polyubiquitination | 9.97e-02 | 1.00e+00 | 3.258 | 1 | 3 | 116 |
GO:0000790 | nuclear chromatin | 1.10e-01 | 1.00e+00 | 3.104 | 1 | 6 | 129 |
GO:0006413 | translational initiation | 1.12e-01 | 1.00e+00 | 3.082 | 1 | 7 | 131 |
GO:0007507 | heart development | 1.18e-01 | 1.00e+00 | 2.997 | 1 | 7 | 139 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 3 | 149 |
GO:0000398 | mRNA splicing, via spliceosome | 1.38e-01 | 1.00e+00 | 2.758 | 1 | 15 | 164 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.44e-01 | 1.00e+00 | 2.698 | 1 | 2 | 171 |
GO:0005667 | transcription factor complex | 1.47e-01 | 1.00e+00 | 2.664 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.49e-01 | 1.00e+00 | 2.640 | 1 | 5 | 178 |
GO:0032403 | protein complex binding | 1.53e-01 | 1.00e+00 | 2.600 | 1 | 6 | 183 |
GO:0004872 | receptor activity | 1.58e-01 | 1.00e+00 | 2.553 | 1 | 8 | 189 |
GO:0001701 | in utero embryonic development | 1.67e-01 | 1.00e+00 | 2.465 | 1 | 8 | 201 |
GO:0008134 | transcription factor binding | 1.98e-01 | 1.00e+00 | 2.197 | 1 | 18 | 242 |
GO:0000166 | nucleotide binding | 2.10e-01 | 1.00e+00 | 2.099 | 1 | 13 | 259 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.14e-01 | 1.00e+00 | 2.071 | 1 | 23 | 264 |
GO:0005743 | mitochondrial inner membrane | 2.23e-01 | 1.00e+00 | 2.002 | 1 | 6 | 277 |
GO:0019899 | enzyme binding | 2.23e-01 | 1.00e+00 | 2.002 | 1 | 9 | 277 |
GO:0006355 | regulation of transcription, DNA-templated | 2.25e-01 | 1.00e+00 | 1.154 | 2 | 43 | 997 |
GO:0043234 | protein complex | 2.36e-01 | 1.00e+00 | 1.911 | 1 | 11 | 295 |
GO:0016021 | integral component of membrane | 2.61e-01 | 1.00e+00 | 0.748 | 3 | 17 | 1982 |
GO:0015031 | protein transport | 2.67e-01 | 1.00e+00 | 1.702 | 1 | 11 | 341 |
GO:0043565 | sequence-specific DNA binding | 2.71e-01 | 1.00e+00 | 1.681 | 1 | 11 | 346 |
GO:0008285 | negative regulation of cell proliferation | 2.75e-01 | 1.00e+00 | 1.652 | 1 | 10 | 353 |
GO:0000139 | Golgi membrane | 2.81e-01 | 1.00e+00 | 1.620 | 1 | 7 | 361 |
GO:0005925 | focal adhesion | 2.84e-01 | 1.00e+00 | 1.600 | 1 | 9 | 366 |
GO:0046982 | protein heterodimerization activity | 2.93e-01 | 1.00e+00 | 1.546 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 3.01e-01 | 1.00e+00 | 1.505 | 1 | 15 | 391 |
GO:0003677 | DNA binding | 3.02e-01 | 1.00e+00 | 0.865 | 2 | 49 | 1218 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.15e-01 | 1.00e+00 | 1.426 | 1 | 24 | 413 |
GO:0055114 | oxidation-reduction process | 3.19e-01 | 1.00e+00 | 1.401 | 1 | 10 | 420 |
GO:0043066 | negative regulation of apoptotic process | 3.22e-01 | 1.00e+00 | 1.388 | 1 | 16 | 424 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.55e-01 | 1.00e+00 | 1.215 | 1 | 24 | 478 |
GO:0042802 | identical protein binding | 3.58e-01 | 1.00e+00 | 1.197 | 1 | 19 | 484 |
GO:0070062 | extracellular vesicular exosome | 3.71e-01 | 1.00e+00 | 0.472 | 3 | 57 | 2400 |
GO:0016032 | viral process | 3.88e-01 | 1.00e+00 | 1.055 | 1 | 26 | 534 |
GO:0005634 | nucleus | 3.95e-01 | 1.00e+00 | 0.283 | 5 | 159 | 4559 |
GO:0006915 | apoptotic process | 4.00e-01 | 1.00e+00 | 0.999 | 1 | 12 | 555 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.08e-01 | 1.00e+00 | 0.961 | 1 | 37 | 570 |
GO:0005886 | plasma membrane | 4.19e-01 | 1.00e+00 | 0.366 | 3 | 49 | 2582 |
GO:0005794 | Golgi apparatus | 4.30e-01 | 1.00e+00 | 0.863 | 1 | 9 | 610 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 4.76e-01 | 1.00e+00 | 0.666 | 1 | 39 | 699 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.19e-01 | 1.00e+00 | 0.492 | 1 | 41 | 789 |
GO:0005887 | integral component of plasma membrane | 5.62e-01 | 1.00e+00 | 0.321 | 1 | 10 | 888 |
GO:0007165 | signal transduction | 5.70e-01 | 1.00e+00 | 0.291 | 1 | 13 | 907 |
GO:0005739 | mitochondrion | 6.06e-01 | 1.00e+00 | 0.153 | 1 | 23 | 998 |
GO:0044281 | small molecule metabolic process | 6.80e-01 | 1.00e+00 | -0.126 | 1 | 20 | 1211 |
GO:0005524 | ATP binding | 7.07e-01 | 1.00e+00 | -0.226 | 1 | 31 | 1298 |
GO:0046872 | metal ion binding | 7.09e-01 | 1.00e+00 | -0.236 | 1 | 29 | 1307 |
GO:0005730 | nucleolus | 7.92e-01 | 1.00e+00 | -0.565 | 1 | 66 | 1641 |